Octagon Capital Advisors LP Gossamer Bio, Inc. Transaction History
Octagon Capital Advisors LP
- $449 Million
- Q4 2024
A detailed history of Octagon Capital Advisors LP transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Octagon Capital Advisors LP holds 18,350,000 shares of GOSS stock, worth $22.6 Million. This represents 3.68% of its overall portfolio holdings.
Number of Shares
18,350,000
Previous 9,187,883
99.72%
Holding current value
$22.6 Million
Previous $9.1 Million
81.56%
% of portfolio
3.68%
Previous 2.2%
Shares
9 transactions
Others Institutions Holding GOSS
# of Institutions
116Shares Held
163MCall Options Held
821KPut Options Held
557K-
Nea Management Company, LLC Timonium, MD18.1MShares$22.3 Million1.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$12.3 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL8.81MShares$10.8 Million0.03% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$9.91 Million4.56% of portfolio
-
683 Capital Management, LLC New York, NY6.98MShares$8.58 Million0.45% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $116M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...